Enhanced Docetaxel Delivery Using Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: In Vitro and In Vivo Antitumor Efficacy Against SKOV3 Ovarian Cancer Cells
Publication date: Available online 4 May 2020Source: International Journal of PharmaceuticsAuthor(s): Chang Hyun Kim, Tae Hoon Kang, Byoung Deok Kim, Tae Hwa Lee, Ho Yub Yoon, Yoon Tae Goo, Yong Seok Choi, Myung Joo Kang, Young Wook Choi
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Docetaxel | Drugs & Pharmacology | Nanotechnology | Ovarian Cancer | Ovaries | Taxotere